Supernus Pharmaceuticals (SUPN) PT Raised to $25 at Stifel
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Price: $47.98 -0.6%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Stifel analyst Annabel Samimy raised the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $25.00 (from $23.00) while maintaining a Hold rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Sunac China Holdings Limited (1918:HK) (SCCCF) PT Lowered to HK$0.30 at JPMorgan
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
